A retrospective real-world study of the current treatment pathways for myelofibrosis in the United Kingdom: the REALISM UK study

BACKGROUND: Myelofibrosis (MF) is a blood cancer associated with splenomegaly, blood count abnormalities, reduced life expectancy and high prevalence of disease-associated symptoms. Current treatment options for MF are diverse, with limited data on management strategies in real-world practice in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Mead, Adam J., Butt, Nauman M., Nagi, Waseem, Whiteway, Alastair, Kirkpatrick, Suriya, Rinaldi, Ciro, Roughley, Catherine, Ackroyd, Sam, Ewing, Joanne, Neelakantan, Pratap, Garg, Mamta, Tucker, David, Murphy, John, Patel, Hitesh, Bains, Rozinder, Chiu, Gavin, Hickey, Joe, Harrison, Claire, Somervaille, Tim C. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966129/
https://www.ncbi.nlm.nih.gov/pubmed/35371428
http://dx.doi.org/10.1177/20406207221084487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966129/
https://www.ncbi.nlm.nih.gov/pubmed/35371428
http://dx.doi.org/10.1177/20406207221084487

Ejemplares similares